Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balances (in shares) at Dec. 31, 2022 26,443,067        
Balances at Dec. 31, 2022   $ 128,078 $ (74) $ (96,177) $ 31,827
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 4,289        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense   422 0 0 422
Unrealized loss on marketable securities   0 45 0 45
Net loss   0 0 (5,272) (5,272)
Issuance of common shares in settlement of deferred stock units (in shares) 17,621        
Balances (in shares) at Mar. 31, 2023 26,464,977        
Balances at Mar. 31, 2023   128,500 (29) (101,449) 27,022
Balances (in shares) at Dec. 31, 2022 26,443,067        
Balances at Dec. 31, 2022   128,078 (74) (96,177) 31,827
Unrealized loss on marketable securities         11
Net loss         $ (9,749)
Issuance of common shares in settlement of deferred stock units (in shares)         17,621
Balances (in shares) at Jun. 30, 2023 37,949,422        
Balances at Jun. 30, 2023   165,732 (63) (105,926) $ 59,743
Balances (in shares) at Mar. 31, 2023 26,464,977        
Balances at Mar. 31, 2023   128,500 (29) (101,449) 27,022
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 4,289        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense   380 0 0 380
Unrealized loss on marketable securities   0 (34) 0 (34)
Net loss   0 0 (4,477) (4,477)
Issuance of common shares net of offering costs (in shares) 11,480,156        
Issuance of common shares net of offering costs   36,852 0 0 36,852
Balances (in shares) at Jun. 30, 2023 37,949,422        
Balances at Jun. 30, 2023   165,732 (63) (105,926) 59,743
Balances (in shares) at Dec. 31, 2023 37,958,000        
Balances at Dec. 31, 2023   166,609 6 (115,558) 51,057
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 5,916        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense $ 0 488 0 0 488
Unrealized loss on marketable securities   0 (45) 0 (45)
Net loss   0 0 (5,151) (5,151)
Balances (in shares) at Mar. 31, 2024 37,963,916        
Balances at Mar. 31, 2024   167,097 (39) (120,709) 46,349
Balances (in shares) at Dec. 31, 2023 37,958,000        
Balances at Dec. 31, 2023   166,609 6 (115,558) 51,057
Unrealized loss on marketable securities         (57)
Net loss         $ (10,270)
Issuance of common shares upon the exercise of common stock options (in shares)         2,750
Balances (in shares) at Jun. 30, 2024 42,692,582        
Balances at Jun. 30, 2024   179,294 (51) (125,828) $ 53,415
Balances (in shares) at Mar. 31, 2024 37,963,916        
Balances at Mar. 31, 2024   167,097 (39) (120,709) 46,349
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares) 5,916        
Issuance of common shares upon the vesting and settlement of restricted stock units   0 0 0 0
Share-based compensation expense   443 0 0 443
Unrealized loss on marketable securities   0 (12) 0 (12)
Net loss   0 0 (5,119) (5,119)
Issuance of common shares net of offering costs (in shares) 4,720,000        
Issuance of common shares net of offering costs   11,747 0 0 11,747
Issuance of common shares upon the exercise of common stock options (in shares) 2,750        
Issuance of common shares upon the exercise of common stock options   7 0 0 7
Balances (in shares) at Jun. 30, 2024 42,692,582        
Balances at Jun. 30, 2024   $ 179,294 $ (51) $ (125,828) $ 53,415